2021-06-09T05:55:34-05:00 2020-10-31 BKD LLP 14241 DALLAS PARKWAY SUITE 1100 DALLAS TX 75254 990 2019-11-01 760442781 El Centro De Corazon % MARCELLE MIR ELCE 7136601880 PO Box 230209 Houston TX 77223 MARCELLE MIR CEO 7136601880 2021-03-15 true Jeanette Verrelli P00742631 9727028262 2019 2022-09-23 18:48:47Z MARCELLE MIR PO BOX 230209 HOUSTON TX 77223 12857163 false X WWW.ELCENTRODECORAZON.ORG X 1994 TX TO BE THE LEADER IN IMPROVING THE WELL-BEING OF THE COMMUNITIES WE SERVE THROUGH THE PROVISION OF QUALITY HEALTH CARE AND THE DELIVERY OF INNOVATIVE PROGRAMS. 9 9 113 10 0 0 4711227 6247966 6634901 6492799 -1189 150 255115 54250 11600054 12795165 0 0 0 0 7671976 8391171 0 0 232534 4182141 3653670 11854117 12044841 -254063 750324 8615311 9085669 2147592 1866987 6467719 7218682 X TO BE THE LEADER IN IMPROVING THE WELL-BEING OF THE COMMUNITIES WE SERVE THROUGH THE PROVISION OF QUALITY HEALTH CARE AND THE DELIVERY OF INNOVATIVE PROGRAMS. false false 8712703 6494389 PEDIATRICS/FAMILY MEDICINE: HEALTH CARE IS OFFERED TO LOW INCOME, UNINSURED, AND UNDERINSURED CHILDREN AND FAMILIES. IN FISCAL YEAR 2020 EL CENTRO HAD 9,881 PEDIATRIC ENCOUNTERS AND 6,713 FAMILY MEDICINE ENCOUNTERS. DENTAL: DENTAL CARE IS OFFERED TO LOW INCOME, UNINSURED, AND UNDERINSURED CHILDREN. IN FISCAL YEAR 2020, EL CENTRO HAD 4,756 DENTAL ENCOUNTERS. PRE-NATAL: EL CENTRO ALSO OFFERS PRE-NATAL CARE AND OTHER OBSTETRIC SERVICES. IN FISCAL YEAR 2020, EL CENTRO HAD 14,900 OB/GYN ENCOUNTERS. IN ADDITION, EL CENTRO PROVIDES MENTAL HEALTH SERVICES. IN FISCAL YEAR 2020, EL CENTRO HAD 6,121 MENTAL HEALTH ENCOUNTERS. 8712703 true true false false false false false false false false true false false false false false true false false false false false false false true false false false false true false false false false false false false false false false false false false false false false false true 26 0 113 true false false false false false true true false false false false false false X 9 9 false false false false false false false true true false false true true true true true true true true false X MARCELLE MIR 7136601880 7037 CAPITOL ST STE N100 HOUSTON TX 77011 X MOHAMMAD SARFRAZ PHYSICIAN 40.0 0.0 X 262312 0 12955 KAVON YOUNG PHYSICIAN 40.0 0.0 X 216369 0 6535 ANAYDA LANDRY PHYSICIAN 40.0 0.0 X 181785 0 23753 DANELIA CASTELLON PHYSICIAN 40.0 0.0 X 182618 0 20290 CARMEN THORNTON PHYSICIAN 40.0 0.0 X 160525 0 27412 MARCELLE MIR CEO 40.0 0.0 X 151563 0 11473 Eugenia Legarda Physician 40.0 0.0 X 158175 0 1968 PAULINA PUTMAN CFO 40.0 0.0 X 129158 0 10214 CAROL PARET DIRECTOR 1.0 0.0 X 0 0 0 LUPE OLIVAREZ JR DIRECTOR 1.0 0.0 X 0 0 0 MELISSA FISHER CHAIR 1.0 0.0 X X 0 0 0 MICHAEL HINOJOSA VICE CHAIR 1.0 0.0 X X 0 0 0 NIKE OTUYELU SECRETARY 1.0 0.0 X X 0 0 0 MARK VAN ELDEN TREASURER 1.0 0.0 X X 0 0 0 MARK ARMSTRONG DIRECTOR 1.0 0.0 X 0 0 0 TOM PERICH DIRECTOR 1.0 0.0 X 0 0 0 Maria Pereyra-Gonzalez DIRECTOR 1.0 0.0 X 0 0 0 1442505 0 114600 16 false true false KNS CONSULTING 2601 CARTWRIGHT ROAD SUITE 144 MISSOURI CITY TX 77459 TECHNOLOGY 263009 LABORATORY CORPORATION OF AMERICA PO BOX 12140 BURLINGTON NC 27216 LABORATORY 272173 UNITED SOLUTIONS 3030 E 29TH STREET BRYAN TX 77802 THIRD PARTY BILLING 248702 3 74569 3530387 2643010 6247966 Net Patient Service Revenue 624100 6445572 6445572 QUALITY INCENTIVE REVENUE 900099 47227 47227 6492799 150 150 0 0 0 0 0 0 61998 74569 61998 0 0 0 0 0 0 Other Revenue 900099 2069 2069 INSURANCE PROCEEDS 900099 50591 50591 MEDICAL RECORD REVENUE 561000 1590 1590 54250 12795165 6494389 52810 0 0 0 0 641290 641290 0 6525972 5063430 1275990 186552 142211 102073 35863 4275 539526 391478 137546 10502 542172 327847 202523 11802 0 0 75570 75570 0 0 0 726022 586360 139635 27 39576 12500 15762 11314 641734 561509 77957 2268 372354 260850 111504 0 439380 325141 114239 28195 28170 25 0 15903 68 15835 34819 34819 0 322204 238431 83773 72778 45802 26976 Bad Debt Expense 229392 229392 Dues and subscriptions 108125 102356 5769 Repairs & Maintenance 254957 188668 66289 Provider referrals 237284 237284 55377 39514 15863 12044841 8712703 3099604 232534 2368751 3362088 638923 613057 490867 105888 596074 600576 0 0 0 0 0 0 155264 164796 79888 59168 6318913 2138817 4285544 4180096 0 0 0 0 0 0 0 0 0 0 8615311 9085669 943739 696514 0 0 0 0 0 0 0 0 0 0 1203853 1170473 0 0 0 0 2147592 1866987 X 5895650 6520434 572069 698248 6467719 7218682 8615311 9085669 750324 639 X false true X true true true X 3965553 4274664 4440297 4711227 6247966 23639707 0 0 3965553 4274664 4440297 4711227 6247966 23639707 0 23639707 652 649 521 648 150 2620 0 0 0 0 0 0 51413 62073 199179 311004 114658 738327 24380654 33637186 0.96961 0.97130 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 299372 299372 4474893 1141869 3333024 2250 2250 1072854 895365 177489 469544 99333 370211 4180096 13048177 546735 1312592 1859327 11188850 1606315 1606315 12795165 12423393 546096 61848 607944 11815449 229392 229392 12044841 SCHEDULE D, PART X, LINE 2 ASC 740 FOOTNOTE: MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS. SCHEDULE D, PART XI, LINE 2D RECONCILIATION OF REVENUE PER AUDITED FINANCIALS WITH RETURN: NET ASSETS RELEASED FROM RESTRICTION $1,541,984 BAD DEBT EXPENSE (229,392) -------------- TOTAL $1,312,592 SCHEDULE D, PART XI, LINE 4B RECONCILIATION OF REVENUE PER AUDITED FINANCIALS WITH RETURN: CONTRIBUTIONS WITH DONOR RESTRICTIONS $1,668,163 INTEREST INCOME 150 FUNDRAISING EXPENSES (61,998) -------------- TOTAL $1,606,315 SCHEDULE D, PART XII, LINE 2D RECONCILIATION OF EXPENSES PER AUDITED FINANCIALS WITH RETURN: INTEREST INCOME $ (150) FUNDRAISING EXPENSES 61,998 --------- TOTAL $61,848 SCHEDULE D, PART XII, LINE 4B RECONCILIATION OF EXPENSES PER AUDITED FINANCIALS WITH RETURN: BAD DEBT EXPENSE $229,392 LUNCHEON 136567 74569 61998 2500 19805 18799 20894 0 136567 74569 61998 2500 19805 18799 20894 61998 X X false false false false false true false true false MARCELLE MIR CEO 149396 0 2167 0 0 0 4728 0 6745 0 163036 0 0 0 MOHAMMAD SARFRAZ PHYSICIAN 261312 0 1000 0 0 0 2102 0 10853 0 275267 0 0 0 KAVON YOUNG PHYSICIAN 212869 0 3500 0 0 0 4277 0 2258 0 222904 0 0 0 DANELIA CASTELLON PHYSICIAN 181618 0 1000 0 0 0 19000 0 1290 0 202908 0 0 0 ANAYDA LANDRY PHYSICIAN 180785 0 1000 0 0 0 18222 0 5531 0 205538 0 0 0 CARMEN THORNTON PHYSICIAN 159525 0 1000 0 0 0 25000 0 2412 0 187937 0 0 0 Eugenia Legarda Physician 157175 0 1000 0 0 0 0 0 1968 0 160143 0 0 0 SCHEDULE J, PART I, LINE 7 NON-FIXED PAYMENTS: EL CENTRO IS COMPETITIVE IN THE MARKETPLACE AND AWARDS ALL EMPLOYEES WITH ANNUAL DISCRETIONARY BONUSES BASED ON EACH EMPLOYEE'S LEVEL OF PERFORMANCE THROUGHOUT THE YEAR. THE DISCRETIONARY BONUS IS DEPENDENT ON THE OVERALL FINANCIAL HEALTH OF THE ORGANIZATION ON A YEAR TO YEAR BASIS. SCHEDULE J, PART I, LINE 6A COMPENSATION CONTINGENT ON NET EARNINGS: IN 2020, THE CEO RECEIVED A BONUS THAT IS BASED ON GOALS THAT ARE AGREED UPON BY THE CEO AND THE BOARD OF DIRECTORS. THE NET EARNINGS OF THE ORGANIZATION IS A CONSIDERATION IN THE PAYMENT OF THE BONUS. FORM 990, PART VI, SECTION A, LINE 1A DELEGATION OF AUTHORITY: THE EXECUTIVE COMMITTEE CONSISTS OF THE BOARD CHAIR, VICE CHAIR, TREASURER AND SECRETARY. THE COMMITTEE HAS MONTHLY CALLS WITH THE CEO TO REVIEW THE NEEDS AND TRENDS OF THE ORGANIZATION BETWEEN BOARD MEETINGS. THE COMMITTEE SHALL HAVE ALL THE POWERS OF THE BOARD WHEN THE BOARD IS NOT IN SESSION AND ALL ACTIONS WILL BE SUBSEQUENTLY RATIFIED BY THE FULL BOARD. FORM 990, PART VI, SECTION B, LINE 11B PROCESS TO REVIEW THE FORM 990: THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM BASED ON THE AUDITED FINANCIAL STATEMENTS AND INFORMATION PROVIDED BY THE ACCOUNTING DEPARTMENT OF THE ORGANIZATION. A DRAFT OF THE 990 WILL BE REVIEWED BY TOP MANAGEMENT AND THE FINANCE COMMITTEE PRIOR TO A FINAL DRAFT REVIEW BY THE FULL BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C PROCESS TO MONITOR COMPLIANCE WITH CONFLICT OF INTEREST POLICY: THE PURPOSE OF THE CONFLICT OF INTEREST POLICY IS TO PROTECT THE CORPORATION'S INTEREST WHEN IT IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF AN OFFICER OR DIRECTOR (INTERESTED PERSON) OF THE CORPORATION. PROCEDURE: IN CONNECTION WITH A PROPOSED TRANSACTION OR ARRANGEMENT, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE AND NATURE OF HIS OR HER FINANCIAL INTEREST TO THE DIRECTORS AND MEMBERS OF THE BOARD OR, IF APPLICABLE, BOARD COMMITTEE CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DETERMINE IF A CONFLICT OF INTEREST EXISTS. IF A CONFLICT OF INTEREST IS DETERMINED TO EXIST, THE INTERESTED PERSON SHALL NOT VOTE ON THE PROPOSED TRANSACTION OR ARRANGEMENT, AND MAY NOT BE PRESENT WHEN THE PROPOSED TRANSACTION OR ARRANGEMENT IS DISCUSSED, UNLESS THE REMAINING BOARD MEMBERS REQUEST THE INTERESTED PERSON'S INPUT FOR INFORMATIONAL PURPOSES. AN INTERESTED PERSON HAS A FINANCIAL INTEREST IF THE INTERESTED PERSON HAS, DIRECTLY OR INDIRECTLY, THROUGH BUSINESS INVESTMENT OR FAMILY: (I) AN OWNERSHIP (OR POTENTIAL OWNERSHIP) INTEREST IN ANY ENTITY WITH WHICH THE CORPORATION HAS A TRANSACTION OR ARRANGEMENT, OR (II) A COMPENSATION ARRANGEMENT (OR POTENTIAL COMPENSATION ARRANGEMENT) WITH ANY ENTITY OR INDIVIDUAL WITH WHICH THE CORPORATION HAS A TRANSACTION OR ARRANGEMENT (OR POTENTIAL TRANSACTION OR ARRANGEMENT). ANNUAL STATEMENT SIGNED BY THE BOARD MEMBER: A STATEMENT ACKNOWLEDGING THAT He/She HAVE READ, UNDERSTAND, AND ACCEPT THE TERMS OF THE POLICY STATEMENT IS NECESSARY TO COMPLY WITH THE PROVISIONS OF THE BYLAWS AND MEET IRS REQUIREMENT. "I AM FAMILIAR WITH THE EL CENTRO'S POLICIES REGARDING CONFLICTS OF INTEREST, AND I AGREE TO DISCLOSE ANY PERSONAL INTEREST, OR POTENTIAL CONFLICTS OF INTEREST, THAT I MAY HAVE IN ANY MATTER PENDING BEFORE ME AND I SHALL REFRAIN FROM PARTICIPATION IN ANY DECISION ON SUCH MATTER." ALL STAFF MEMBERS, INCLUDING CORPORATE OFFICERS, ARE ALSO REQUIRED TO ANNUALLY CONSIDER POTENTIAL CONFLICTS OF INTERESTS. STAFF IS EXPECTED TO AVOID SITUATIONS WHERE THERE MAY APPEAR TO BE A CONFLICT BETWEEN WHAT IS IN HIS/HER BEST INTEREST AND THE BEST INTEREST OF EL CENTRO OR ITS PATIENTS. FORM 990, PART VI, SECTION B, LINE 15A CEO AND TOP MANAGEMENT OFFICIAL COMPENSATION REVIEW: THE BOARD OF DIRECTORS ANNUALLY REVIEWS THE CHIEF EXECUTIVE OFFICER'S COMPENSATION AND DETERMINES COMPENSATION USING THE ANNUAL TACHC SALARY AND BENEFIT REPORT. THE REVIEW IS DOCUMENTED IN THE HR ADMINISTRATOR'S FILES. FORM 990, PART VI, SECTION B, LINE 15B OTHER OFFICERS AND KEY EMPLOYEES COMPENSATION REVIEW: A REVIEW OCCURS ANNUALLY AT THE END OF EACH FISCAL YEAR. THE CEO EVALUATES OTHERS IN THE MANAGEMENT TEAM USING THE ANNUAL TACHC SALARY AND BENEFIT REPORT, AND THE MANAGEMENT TEAM AND DEPARTMENT HEAD MAKE COMPENSATION DECISIONS FOR THE REMAINING EMPLOYEES. THE LAST COMPENSATION REVIEW WAS PERFORMED IN JANUARY 2021 BY MARCELLE MIR, CEO. THE REVIEW IS DOCUMENTED IN THE HR ADMINISTRATOR'S FILES. FORM 990, PART VI, SECTION C, LINE 19 AVAILABILITY OF DOCUMENTS: ORGANIZATION DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST FOR A LEGITIMATE BUSINESS PURPOSE, AS DETERMINED BY TOP MANAGEMENT. DEPENDING ON THE DOCUMENTS REQUESTED, THE ITEMS WILL EITHER BE EMAILED OR AVAILABLE FOR ON-SITE VIEWING.